Morgan Stanley
EMMA

Morgan Stanley’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Morgan Stanley’s Portfolio EMMA Stock Details EMMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-42
Closed – – 6908
2019
Q2 		$0 Hold
42
– – ﹤0.01% 6872
2019
Q1 		$0 Hold
42
– – ﹤0.01% 6821
2018
Q4 		$0 Hold
42
– – ﹤0.01% 6846
2018
Q3 		$0 Buy
+42
New +$416 ﹤0.01% 6907

Other funds holding EMMA

MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Morgan Stanley's EMMA Position: Q3 2019 in Review

Morgan Stanley sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2019, closing a stake of 42 shares.

Morgan Stanley first reported a position in EMMA in Q3 2018 and held it in 4 quarters. The position peaked at $0 in Q2 2019. 1 fund tracked by Wall St. Rank holds EMMA as of Q3 2019.

  • Morgan Stanley reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Morgan Stanley sold 42 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2019.
  • Morgan Stanley first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
  • Morgan Stanley's Emmaus Life Sciences, Inc. Common Stock position peaked at $0 in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2019.

Based on Morgan Stanley's 13F filing for Q3 2019, filed 14 Nov 2019.